During a live event, Pedro C. Barata, MD, MSc, discussed the case of a patient with advanced clear cell renal cell carcinoma who requires second-line therapy.

The antibody-drug conjugate is approved for previously treated advanced NSCLC patients with high c-Met protein overexpression ...

Recent novel treatments for chronic lymphocytic leukemia (CLL), such as second-generation covalent Bruton tyrosine kinase inhibitors (cBTKis) and venetoclax-obinutuzumab (VenO), may offer better ...

The technique used on a 9½-month-old boy with a rare condition has the potential to help people with thousands of other ...

Tics and BFRBs may seem alike, but knowing the difference can shape treatment and improve outcomes. Here's what you need to ...

This is a completely new paradigm of treatment for depression, and it actually works,” Dr. Aaron Tendler told The Post.

Successfully treating type 2 diabetes may involve focusing on brain neurons, rather than simply concentrating on obesity or ...

There are neuroprotective ways to build connection with our children and be the mirror that reflects their latent magic.

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

Patients with haemophilia A got their first gene therapy option last year, when the European Commission approved BioMarin's Roctavian (valoctocogene roxaparvovec). The first quarter of 2025 saw a ...